The study reveals a statistically significant reduction in ADAMTS13 activity and an elevation in soluble C5b-9 levels among a group of pregnant women who developed early onset severe preeclampsia, compared to a healthy control group. The gene discussed is ADAMTS13; the disease is preeclampsia.